KALA BIO, INC. Interest Expense Nonoperating
KALA BIO, INC. (KALA) reported Interest Expense Nonoperating of $3.28 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-19
- KALA BIO, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $141.00K, a 89.87% decline year-over-year.
- KALA BIO, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $963.00K, a 34.84% decline year-over-year.
- KALA BIO, INC. interest expense nonoperating for the quarter ending 2025-06-30 was $1.08M, a 25.86% decline year-over-year.
- KALA BIO, INC. interest expense nonoperating for the quarter ending 2025-03-31 was $1.09M, a 25.02% decline year-over-year.
- KALA BIO, INC. interest expense nonoperating for fiscal 2025 was $3.28M, a 43.35% decline from fiscal 2024.
- KALA BIO, INC. interest expense nonoperating for fiscal 2024 was $5.78M, a 0.53% decline from fiscal 2023.
- KALA BIO, INC. interest expense nonoperating for fiscal 2023 was $5.81M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2025-12-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $1.10M derived: sum of 2 quarters · filed 2026-04-15 | $2.19M derived: sum of 3 quarters · filed 2026-08-19 | $3.28M 10-K · filed 2026-04-15 |
| 2025-09-30 | $963.00K 10-Q · filed 2025-11-19 | $2.04M derived: sum of 2 quarters · filed 2026-08-19 | $3.13M 10-Q · filed 2025-11-19 | $4.53M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $1.08M 10-Q · filed 2026-08-19 | $2.17M 10-Q · filed 2026-08-19 | $3.56M derived: sum of 3 quarters · filed 2026-08-19 | $5.04M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $1.09M 10-Q · filed 2026-05-15 | $2.48M derived: sum of 2 quarters · filed 2026-05-15 | $3.96M derived: sum of 3 quarters · filed 2026-05-15 | $5.42M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $2.87M derived: sum of 2 quarters · filed 2026-04-15 | $4.33M derived: sum of 3 quarters · filed 2026-04-15 | $5.78M 10-K · filed 2026-04-15 |
| 2024-09-30 | $1.48M 10-Q · filed 2025-11-19 | $2.94M derived: sum of 2 quarters · filed 2025-11-19 | $4.39M 10-Q · filed 2025-11-19 | $5.86M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | $1.46M 10-Q · filed 2025-08-08 | $2.91M 10-Q · filed 2025-08-08 | $4.38M derived: sum of 3 quarters · filed 2025-08-08 | $5.84M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $1.46M 10-Q · filed 2025-05-14 | $2.92M derived: sum of 2 quarters · filed 2025-05-14 | $4.38M derived: sum of 3 quarters · filed 2025-05-14 | $5.79M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $2.93M derived: sum of 2 quarters · filed 2025-03-31 | $4.34M derived: sum of 3 quarters · filed 2025-03-31 | $5.81M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.46M 10-Q · filed 2024-11-12 | $2.87M derived: sum of 2 quarters · filed 2024-11-12 | $4.35M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $1.41M 10-Q · filed 2024-08-06 | $2.89M 10-Q · filed 2024-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |